Hepatitis C virus DNA vaccines: a systematic review

Virology Journal

Mojtaba Hedayat Yaghoobi¹  Roya Kianfar²  Parastoo Hosseini³  Mehdi Ajorloo⁴  Sayed-Hamidreza Mozhgani⁵  Tayebeh Hashempour⁶  Ali Shayeghpour⁷  Sepehr Aghajanian⁷ 

[1] Department of Infectious Disease, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran;Department of Medical Virology, Tarbiat Modares University, Tehran, Iran;Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran;Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran;Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran;Department of Clinical Laboratory Sciences, School of Allied Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran;Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran;Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran;Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran;Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran;

关键词: Hepatitis C Virus;    Immunogenicity;    Systematic review;    DNA vaccines;    RNA vaccines;    Immune response;   

DOI  :  10.1186/s12985-021-01716-8

来源: Springer

【 摘 要 】

BackgroundVaccination against HCV is an effective measure in reduction of virus-related public health burden and mortality. However, no prophylactic vaccine is available as of yet. DNA-based immunization is a promising modality to generate cellular and humoral immune responses. The objective of this study is to provide a systematic review of HCV DNA vaccines and investigate and discuss the strategies employed to optimize their efficacies.MethodsMEDLINE (PubMed), Web of Science, Scopus, ScienceDirect, and databases in persian language including the Regional Information Centre for Science & Technology (RICeST), the Scientific Information Database and the Iranian Research Institute for Information Science and Technology (IranDoc) were examined to identify studies pertaining to HCV nucleic acid vaccine development from 2000 to 2020.ResultsTwenty-seven articles were included. Studies related to HCV RNA vaccines were yet to be published. A variety of strategies were identified with the potential to optimize HCV DNA vaccines such as incorporating multiple viral proteins and molecular tags such as HBsAg and Immunoglobulin Fc, multi-epitope expression, co-expression plasmid utilization, recombinant subunit immunogens, heterologous prime-boosting, incorporating NS3 mutants in DNA vaccines, utilization of adjuvants, employment of less explored methods such as Gene Electro Transfer, construction of multi- CTL epitopes, utilizing co/post translational modifications and polycistronic genes, among others. The effectiveness of the aforementioned strategies in boosting immune response and improving vaccine potency was assessed.ConclusionsThe recent progress on HCV vaccine development was examined in this systematic review to identify candidates with most promising prophylactic and therapeutic potential.

【 授权许可】

CC BY